SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-011024
Filing Date
2024-03-22
Accepted
2024-03-22 17:28:26
Documents
14
Period of Report
2024-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38344
2 ex99-1.htm EX-99.1 92592
  Complete submission text file 0001493152-24-011024.txt   319142

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT age-20240322.xsd EX-101.SCH 3009
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT age-20240322_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT age-20240322_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3737
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24776342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)